Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haojun Chen

Showing results (21-30 of 148) with videos related to

Pageof 15
Sort By:
Journal of Clinical Laboratory Analysis|July 6, 2019
The long non-coding RNA OLC8 enhances gastric cancer by interaction with IL-11Rongjia Zhou, Zhanbin Wu, Xixiang Deng, et al.
Clinical Nuclear Medicine|July 22, 2022
Serous Cystadenoma of the Pancreas Showing Increased Uptake on 68 Ga-FAPI PET/CTWeizhi Xu, Long Zhao, Tinghua Meng, et al.
Clinical Nuclear Medicine|December 14, 2020
68Ga-Fibroblast Activation Protein Inhibitor, a Promising Radiopharmaceutical in PET/CT to Detect the Primary and Metastatic Lesions of Chromophobe Renal Cell CarcinomaYizhen Pang, Jihong Wei, Qihang Shang, et al.
Clinical Nuclear Medicine|August 18, 2020
Widespread Metastatic Gastric Signet-Ring Cell Carcinoma Shown by 68Ga-FAPI PET/CTChunlei Fan, Wei Guo, Guoqiang Su, et al.
Clinical Nuclear Medicine|February 17, 2023
68 Ga-FAPI Versus 18 F-FDG PET/CT in the Evaluation of Epithelioid Hemangioendothelioma of BoneWeizhi Xu, Jiayu Cai, Tinghua Meng, et al.
Clinical Nuclear Medicine|May 27, 2020
68Ga-FAPI PET/CT Detects Gastric Signet-Ring Cell Carcinoma in a Patient Previously Treated for Prostate CancerYizhen Pang, Haichao Huang, Li Fu, et al.
Clinical Nuclear Medicine|September 10, 2021
68Ga-Exendin-4 PET/CT Differentiates Insulinoma From Accessory Spleen in a Patient Presenting Indeterminate MRI and 68Ga-DOTATATE PET/CT FindingsYizhen Pang, Tinghua Meng, Qihang Shang, et al.
Clinical Nuclear Medicine|October 2, 2024
Superior Identification of Metastatic Lesions by 68 Ga-FAPI-46 PET/CT Than 18 F-FDG PET/CT in Hepatic Solitary Fibrous TumorKaili Fu, Liang Zhao, Jiayu Cai, et al.
Clinical Nuclear Medicine|April 29, 2022
FAP-Targeted Radionuclide Therapy of Advanced Radioiodine-Refractory Differentiated Thyroid Cancer With Multiple Cycles of 177 Lu-FAPI-46Hao Fu, Jingxiong Huang, Long Sun, et al.
Clinical Nuclear Medicine|October 15, 2021
68Ga-FAPI PET/CT Distinguishes the Reactive Lymph Nodes From Tumor Metastatic Lymph Nodes in a Patient With Nasopharyngeal CarcinomaQihang Shang, Long Zhao, Yizhen Pang, et al.
Pageof 15

Showing results (21-30 of 148) with videos related to

Sort By:
Pageof 15
Journal of Clinical Laboratory Analysis|July 6, 2019
The long non-coding RNA OLC8 enhances gastric cancer by interaction with IL-11Rongjia Zhou, Zhanbin Wu, Xixiang Deng, et al.
Clinical Nuclear Medicine|July 22, 2022
Serous Cystadenoma of the Pancreas Showing Increased Uptake on 68 Ga-FAPI PET/CTWeizhi Xu, Long Zhao, Tinghua Meng, et al.
Clinical Nuclear Medicine|December 14, 2020
68Ga-Fibroblast Activation Protein Inhibitor, a Promising Radiopharmaceutical in PET/CT to Detect the Primary and Metastatic Lesions of Chromophobe Renal Cell CarcinomaYizhen Pang, Jihong Wei, Qihang Shang, et al.
Clinical Nuclear Medicine|August 18, 2020
Widespread Metastatic Gastric Signet-Ring Cell Carcinoma Shown by 68Ga-FAPI PET/CTChunlei Fan, Wei Guo, Guoqiang Su, et al.
Clinical Nuclear Medicine|February 17, 2023
68 Ga-FAPI Versus 18 F-FDG PET/CT in the Evaluation of Epithelioid Hemangioendothelioma of BoneWeizhi Xu, Jiayu Cai, Tinghua Meng, et al.
Clinical Nuclear Medicine|May 27, 2020
68Ga-FAPI PET/CT Detects Gastric Signet-Ring Cell Carcinoma in a Patient Previously Treated for Prostate CancerYizhen Pang, Haichao Huang, Li Fu, et al.
Clinical Nuclear Medicine|September 10, 2021
68Ga-Exendin-4 PET/CT Differentiates Insulinoma From Accessory Spleen in a Patient Presenting Indeterminate MRI and 68Ga-DOTATATE PET/CT FindingsYizhen Pang, Tinghua Meng, Qihang Shang, et al.
Clinical Nuclear Medicine|October 2, 2024
Superior Identification of Metastatic Lesions by 68 Ga-FAPI-46 PET/CT Than 18 F-FDG PET/CT in Hepatic Solitary Fibrous TumorKaili Fu, Liang Zhao, Jiayu Cai, et al.
Clinical Nuclear Medicine|April 29, 2022
FAP-Targeted Radionuclide Therapy of Advanced Radioiodine-Refractory Differentiated Thyroid Cancer With Multiple Cycles of 177 Lu-FAPI-46Hao Fu, Jingxiong Huang, Long Sun, et al.
Clinical Nuclear Medicine|October 15, 2021
68Ga-FAPI PET/CT Distinguishes the Reactive Lymph Nodes From Tumor Metastatic Lymph Nodes in a Patient With Nasopharyngeal CarcinomaQihang Shang, Long Zhao, Yizhen Pang, et al.
Pageof 15